logo

Barnes Group Inc (B)



Trade B now with
  Date
  Headline
9/11/2019 11:04:54 AM Barnes Group Appoints Daphne Jones To Board
8/27/2019 10:36:43 AM Barnes Group Announces Passing Of Board Member Gary Benanav
7/26/2019 6:33:18 AM Barnes Q2 Sales Of $372 Mln, Down 1% From Last Year; Organic Sales Down 4%
7/26/2019 6:32:17 AM Barnes Group Q2 GAAP EPS Of $0.73; Adj. EPS Of $0.75, Down 17%
7/18/2019 12:05:05 PM Barnes Group Inc (B) Declares Quarterly Dividend of $ 0.16, Record Date 8/26/2019
5/3/2019 9:13:19 AM Barnes Group Inc (B) Declares Quarterly Dividend of $ 0.16, Record Date 5/24/2019
4/26/2019 6:34:24 AM Barnes Group Q1 GAAP EPS $0.65; Adjusted EPS $0.71
2/22/2019 6:33:05 AM Barnes Group Q4 GAAP EPS $0.75; Adjusted EPS $0.84
2/7/2019 9:03:38 AM Barnes Group Appoints Patrick Hurley SVP And Chief Technology Officer
2/4/2019 4:12:25 AM BioArctic Announces That Eisai Will Initiate Phase 3 Confirmatory Study With BAN2401 In Early Alzheimer's Disease
12/14/2018 2:15:54 AM BioArctic Outlicenses Its Alpha-synuclein Antibody Portfolio For Parkinson's Disease To AbbVie After Receiving Clearance
11/19/2018 4:33:17 PM Luxfer Appoints Richard Hipple To Board Of Directors
11/1/2018 11:14:19 PM BioArctic's Partner AbbVie Exercises Option To License Alpha-synuclein Antibody Portfolio For Parkinson's Disease
10/31/2018 11:06:11 AM Barnes Group Completes Acquisition Of Gimatic
  
 
>